NCT01581060 - Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Advanced Solid Tumours

Interventions

DRUG

WX-554

Capsules of WX-554

Trial Locations (5)

Queen's University Belfast Cancer Centre, Belfast

Beatson West of Scotland Cancer Centre, Glasgow

St James' Institute of Oncology, Leeds

Christie NHS Foundation Trust, Oak Road Treatment Centre, Manchester

Sir Bobby Robson Cancer Trials Research Centre, Newcastle upon Tyne